A RARE UTERINE TUMOR: DISSEMINATED PERITONEAL LEIOMYOMATOSIS. CLINICAL OBSERVATIONS

Authors

  • V. Svintsitskyi State non-commercial enterprise “National Cancer Institute”, Kyiv, Ukraine
  • M. Krotevych State non-commercial enterprise “National Cancer Institute”, Kyiv, Ukraine
  • M. Iegorov State non-commercial enterprise “National Cancer Institute”, Kyiv, Ukraine
  • S. Trokhymych State non-commercial enterprise “National Cancer Institute”, Kyiv, Ukraine
  • S. Sendetskyi State non-commercial enterprise “National Cancer Institute”, Kyiv, Ukraine

DOI:

https://doi.org/10.15407/exp-oncology.2023.03.370

Keywords:

uterine tumor, disseminated peritoneal leiomyomatosis, immunohistochemical analysis, surgical treatment

Abstract

Background. Disseminated peritoneal leiomyomatosis (DPL) is an extremely rare benign disease characterized by widespread lesions of the abdominal cavity, pelvis, and retroperitoneal space with tumor nodules of varying size and number, which are benign neoplasms consisting of smooth muscle fibers in their histological structure. Aim. To analyze clinical cases of DPL with a concise review of the current state of the DPL diagnosis and treatment. Materials and Methods. We analyzed 5 clinical cases of DPL of female patients aged 39—50 years (mean age 46.2 years) who underwent surgical treatment at the National Cancer Institute from 2010 to 2021. In all 5 patients, the diagnosis of DPL (8898/1) was verified according to pathological (using routine hematoxylin/eosin staining) and immunohistochemical (IHC) studies. Results. All patients underwent surgical treatment with a laparotomy approach, the extent and radicality of which depended on the location and number of tumor lesions. At the time of follow-up, all 5 patients were alive and did not receive any special oncological treatment. Conclusions. DPL is characterized by a variety of clinical manifestations from polyserositis to acute abdomen, depending on the location and size of the main tumor focus. IHC analysis is the criterion for the final diagnosis, and radical removal of all tumor foci provides the best therapeutic prognosis. The treatment should be carried out in highly specialized cancer centers where surgeons have gained sufficient experience in performing cytoreductive surgery.

References

Andreeva YuYu, Moskvina LV, Frank GA, et al. Smooth muscle tumors of uncertain malignant potential. Arch Pathol. 2019;81(3):5-11 (in Russian). https://doi.org/10.17116/patol2019810315

Momtahan M, Nemati M, Safaei A. Disseminated peritoneal leiomyomatosis. Iran J Med Sci. 2011;36(1):57-59.

Wu C, Zhang X, Tao X, et al. Leiomyomatosis peritonealis disseminata: A case report and review of the literature.

Mol Clin Oncol. 2016;4(6):957-958. https://doi.org/10.3892/mco.2016.848

Smirnova GF, Kirichenko AD, Fetisova TI, et al. Rare case of disseminated peritonealleiomyomatosis. Sib J Oncol. 2010;1:85-87 (in Russian).

Huang SF, Wen CY, Liao CI, et al. Leiomyomatosis peritonealis disseminata mimicking peritoneal carcinomatosis 13 years after laparoscopic uterine myomectomy: A case report. Int J Surg Case Rep. 2021;81:105745. https://doi.org/10.1016/j.ijscr.2021.105745

Askolskaya SI, Kogan EA, Popov YuV, et al. Disseminated peritoneal leiomyomatosis. Obstetr Gynecol. 2014;12:109-112 (in Russian).

Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds. WHO Classification of Tumours of the Female Repro­ ductive Organs. WHO Classification of Tumours, 4th Edition, vol 6. IARC, Lyon, 2014.

Wilson JL, Peale AR. Multiple peritoneal leiomyomas associated with a granulosa-cell tumor of the ovary. Am J Obstet Gynecol. 1952;64(1):204-208.

Taubert HD, Wisser SE, Haskins AL. Leiomyomatosis disseminata; an unusual complication of genital leiomyo- mata. Obstet Gynecol. 1965;25:561-574.

Tavassoli FA, Norris HJ. Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): A clinicopatho- logic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol.1982.1:59-74.

Payanidi YuG, Zhordania KI, Zakharova TI. Tactical errors in the treatment of patients with intravenous leiomyomatosis (clinical observations). Oncogynecol. 2016.2:22-28 (in Russian).

Downloads

Published

28.12.2023

How to Cite

Svintsitskyi, V., Krotevych, M., Iegorov, M., Trokhymych, S., & Sendetskyi, S. (2023). A RARE UTERINE TUMOR: DISSEMINATED PERITONEAL LEIOMYOMATOSIS. CLINICAL OBSERVATIONS. Experimental Oncology, 45(3), 370–378. https://doi.org/10.15407/exp-oncology.2023.03.370

Issue

Section

Original contributions

Most read articles by the same author(s)